If you liked this article you might like

Everything We Know About BioCryst's New HAE Drug
BioCryst Pill Prevents Swelling Attacks but Shares Fall on Competitive Concerns
Biotech Movers: Shire Rises on Encouraging Angioedema Results
Shire Beats Full-Year Earnings Estimates, Sees Robust 2017 Growth